Adenovirus Vaccine Activities for Military Sustainability
Closed Pre-Solicitation Posted
Not the latest version. See the latest special notice from .
- Solicitation number
- W81XWH-20-RFI-TJK4
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Frederick, Maryland 21702, United States
Notice details come from SAM.gov. Updated .
Notice text
United States Army Medical Materiel Device Activity (USAMMDA) is currently seeking information on a services contract for the purpose of evaluating the operations and processes of the Adenovirus vaccine manufacturing for areas of improvement and increased efficiencies. Actions considered necessary to ensure sustainability of an U.S. Food and Drug Administration (FDA) licensed Adenovirus vaccine for Military use.
The US Army has a requirement to sustain an Adenovirus vaccine product in accordance with the Department of Defense (DOD) Acquisition System, FDA regulations and guidelines, and industry best practices. In direct support of the USAMMDA product development effort, the Government is seeking to obtain a plan which outlines the activities necessary to implement process improvements and efficiency enhancements necessary to sustain the viability of an Adenovirus vaccine.
Please see RFI Attachment.
Files
| File | Type | Posted |
|---|---|---|
| RFI - Adenovirus.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Adenovirus Vaccine Activities for Military Sustainability | Special Notice | |
| This notice | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity